Edward P. Feener Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

KALV Quotes by TradingView

Edward P. Feener is CHIEF SCIENTIFIC OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 72,858 shares of KALV, which is worth approximately $858,995. The most recent transaction as insider was on May 20, 2024, when has been sold 8,088 shares (Common Stock) at a price of $11.76 per share, resulting in proceeds of $95,114. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.9K
17.22% 3M change
9.12% 12M change
Total Value Held $858,995

Edward P. Feener Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Open market or private sale
$95,114 $11.76 p/Share
8,088 Reduced 9.99%
72,858 Common Stock
May 17 2024
BUY
Exercise of conversion of derivative security
-
18,789 Added 18.84%
80,946 Common Stock
Feb 20 2024
SELL
Open market or private sale
$404,235 $14.29 p/Share
28,288 Reduced 31.28%
62,157 Common Stock
Feb 17 2024
BUY
Exercise of conversion of derivative security
-
18,788 Added 17.2%
90,445 Common Stock
Feb 14 2024
SELL
Open market or private sale
$422,846 $15.01 p/Share
28,171 Reduced 28.22%
71,657 Common Stock
Feb 11 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 37.54%
99,828 Common Stock
Jan 11 2024
SELL
Open market or private sale
$295,507 $13.03 p/Share
22,679 Reduced 36.28%
39,828 Common Stock
Jan 09 2024
SELL
Open market or private sale
$1,300 $13.0 p/Share
100 Reduced 0.16%
62,507 Common Stock
Jan 08 2024
SELL
Open market or private sale
$224,045 $13.01 p/Share
17,221 Reduced 21.57%
62,607 Common Stock
Nov 20 2023
SELL
Open market or private sale
$40,804 $8.23 p/Share
4,958 Reduced 5.85%
79,828 Common Stock
Nov 17 2023
BUY
Exercise of conversion of derivative security
-
11,497 Added 11.94%
84,786 Common Stock
Aug 18 2023
SELL
Open market or private sale
$53,392 $10.73 p/Share
4,976 Reduced 6.36%
73,289 Common Stock
Aug 17 2023
BUY
Exercise of conversion of derivative security
-
11,494 Added 12.81%
78,265 Common Stock
May 18 2023
SELL
Open market or private sale
$18,110 $10.14 p/Share
1,786 Reduced 2.61%
66,771 Common Stock
May 17 2023
BUY
Exercise of conversion of derivative security
-
4,205 Added 5.78%
68,557 Common Stock
Feb 17 2023
SELL
Open market or private sale
$17,066 $7.66 p/Share
2,228 Reduced 3.35%
64,352 Common Stock
Feb 17 2023
BUY
Exercise of conversion of derivative security
-
4,204 Added 5.94%
66,580 Common Stock
Nov 18 2022
SELL
Open market or private sale
$2,883 $5.44 p/Share
530 Reduced 0.84%
62,376 Common Stock
Nov 17 2022
BUY
Exercise of conversion of derivative security
-
1,774 Added 2.74%
62,906 Common Stock
Aug 17 2022
SELL
Open market or private sale
$7,959 $14.96 p/Share
532 Reduced 0.86%
61,132 Common Stock
Aug 17 2022
BUY
Exercise of conversion of derivative security
-
1,773 Added 2.79%
61,664 Common Stock
Jan 07 2022
BUY
Exercise of conversion of derivative security
$440,499 $7.64 p/Share
57,657 Added 49.05%
59,891 Common Stock
Nov 01 2021
SELL
Open market or private sale
$108,420 $18.07 p/Share
6,000 Reduced 72.87%
2,234 Common Stock
Aug 02 2021
SELL
Open market or private sale
$123,120 $20.52 p/Share
6,000 Reduced 42.15%
8,234 Common Stock
Jun 02 2021
SELL
Open market or private sale
$218,858 $26.69 p/Share
8,200 Reduced 36.55%
14,234 Common Stock
EPF

Edward P. Feener

CHIEF SCIENTIFIC OFFICER
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KALV